Correlation Between Invivyd and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Invivyd and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Invivyd and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Invivyd and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Invivyd and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Invivyd with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Invivyd and Eledon Pharmaceuticals.

Diversification Opportunities for Invivyd and Eledon Pharmaceuticals

0.24

Correlation Coefficient

Invivyd  Eledon Pharmaceuticals

Modest diversification

The 3 months correlation between Invivyd and Eledon is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Invivyd and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Invivyd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Invivyd are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Invivyd i.e., Invivyd and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Invivyd and Eledon Pharmaceuticals

Given the investment horizon of 90 days Invivyd is expected to generate 8.13 times more return on investment than Eledon Pharmaceuticals. However, Invivyd is 8.13 times more volatile than Eledon Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Eledon Pharmaceuticals is currently generating about -0.08 per unit of risk. If you would invest  46.00  in Invivyd on December 29, 2024 and sell it today you would earn a total of  15.00  from holding Invivyd or generate 32.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Invivyd  vs.  Eledon Pharmaceuticals

Invivyd

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Invivyd are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Invivyd exhibited solid returns over the last few months and may actually be approaching a breakup point.

Eledon Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Eledon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Invivyd and Eledon Pharmaceuticals

The main advantage of trading using opposite Invivyd and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Invivyd position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Invivyd and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.